Sam Shevat

Primary is the worlds largest early stage VC firm, with a billion in assets under management and 50 full time employees. Primary’s Impact team outnumbers investors 2:1, and is filled with seasoned executives working alongside founders to supercharge growth and secure quality hires, early customers, and downstream investors. This team embeds with companies for 2,500 hours of high-intensity fractional leadership work, conducts 3,000 candidate interviews, maintains a pool of 5,000+ active job seekers, and hosts 250 events large and small for the NYC tech community each year. Cofounders Brad Svrluga and Ben Sun have won recognition from Forbes Midas List and Insiders Seed 100.

MicroCures develops biopharmaceuticals that harness innate cellular mechanisms within the body to precisely control the rate and direction of cell migration, offering the potential to deliver powerful therapeutic benefits for a variety of large and underserved medical applications. MicroCures has developed a broad pipeline of novel therapeutic programs with an initial focus in the area of tissue, nerve and organ repair. The company’s lead therapeutic candidate, siFi2, targets excisional wound healing, a multi-billion dollar market inadequately served by current treatments. Additional applications for the company’s cell migration accelerator technology include dermal burn repair, corneal burn repair, cavernous nerve regeneration, spinal cord regeneration, and cardiac tissue repair. Cell migration decelerator applications include combatting cancer metastases and fibrosis. The company protects its unique platform and proprietary therapeutic programs with a robust intellectual property portfolio including eight issued or allowed patents, as well as eight pending patent applications. For more information please visit: www.microcures.com

BNM Ventures is a strategic advisory and venture capital firm based in NY and CT.

Primary is the worlds largest early stage VC firm, with a billion in assets under management and 50 full time employees. Primary’s Impact team outnumbers investors 2:1, and is filled with seasoned executives working alongside founders to supercharge growth and secure quality hires, early customers, and downstream investors. This team embeds with companies for 2,500 hours of high-intensity fractional leadership work, conducts 3,000 candidate interviews, maintains a pool of 5,000+ active job seekers, and hosts 250 events large and small for the NYC tech community each year. Cofounders Brad Svrluga and Ben Sun have won recognition from Forbes Midas List and Insiders Seed 100.

MicroCures develops biopharmaceuticals that harness innate cellular mechanisms within the body to precisely control the rate and direction of cell migration, offering the potential to deliver powerful therapeutic benefits for a variety of large and underserved medical applications. MicroCures has developed a broad pipeline of novel therapeutic programs with an initial focus in the area of tissue, nerve and organ repair. The company’s lead therapeutic candidate, siFi2, targets excisional wound healing, a multi-billion dollar market inadequately served by current treatments. Additional applications for the company’s cell migration accelerator technology include dermal burn repair, corneal burn repair, cavernous nerve regeneration, spinal cord regeneration, and cardiac tissue repair. Cell migration decelerator applications include combatting cancer metastases and fibrosis. The company protects its unique platform and proprietary therapeutic programs with a robust intellectual property portfolio including eight issued or allowed patents, as well as eight pending patent applications. For more information please visit: www.microcures.com

NextGen Venture Partners works with over 1,800 Venture Partners to invest $1 million in seed stage companies and $2 million to $10 million in companies with more than $10 million in revenue. Our Venture Partners are top founders and innovation executives across the country whose expertise and connections help NextGen accelerate the growth of our portfolio companies.

Lehman Brothers Holdings Inc. (Pink Sheets: LEHMQ, former NYSE ticker symbol LEH) (pronounced /ˈliːmən/) was a global financial-services firm which, until declaring bankruptcy in 2008, participated in business in investment banking, equity and fixed-income sales, research and trading, investment management, private equity, and private banking. It was a primary dealer in the U.S. Treasury securities market. Its primary subsidiaries included Lehman Brothers Inc., Neuberger Berman Inc., Aurora Loan Services, Inc., SIB Mortgage Corporation, Lehman Brothers Bank, FSB, Eagle Energy Partners, and the Crossroads Group. The firms worldwide headquarters were in New York City, with regional headquarters in London and Tokyo, as well as offices located throughout the world.